2m 2m 2m 2m 2m 2m 2m
Genmab (GNMSF)
OTC
$329.25-$8.75 (-2.59%)
Price as of Sep 04, 2026- N/AMarket Cap
- 19.95%1-Year Change
- BiotechnologyIndustry
Genmab (GNMSF)
$329.25-$8.75 (-2.59%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$329.25
$329.25
$329.25
1-Year Range
$232.34
$352.00
$329.25
Latest Close$329.25
Change
-$8.75 (-2.66%)
Volume6
Information as of 09/04/2026
Company Profile
GENMAB A/S DKK
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
GENMAB A/S DKK
Key Executives
- Jan van de Winkel
- Rayne Waller
- Gregory David Emil Mueller
- Tahamtan Ahmadi
- Judith V. Klimovsky
Current Ownership Distribution
- Other55.5M (90.47%)
- Mutual Funds5.8M (9.49%)
- Institutions22,840 (0.04%)
- Insiders0 (0.00%)